List of Vendor Companies in Connecticut - 27

Red Cross Blood Services is a Hospital and Health Care company located in 78 Eastern Blvd Ste 3, Glastonbury, Connecticut, United States.

ApiJect Systems, Corp. a medical technology company whose device development platform will make the safety and performance advantages of single-use prefilled syringes affordable. The ApiJect Platform enables pharmaceutical and biotech companies to design scalable prefilled injectors and efficiently fill-finish them with their injectable drug products. This can be done either on one of their own ApiJect-licensed Blow-Fill-Seal packaging lines or at one of our world-class manufacturing partners.

ARVYS Proteins Inc. is a Contract Research Organization (CRO) that Specializes in Custom Protein Services for Drug Discovery and Life Science Research. Our strong integrated expertise in protein biochemistry, working experience with various recombinant expression systems and protein classes, up-to-date knowledge in protein technologies, enable us to become a reliable and resourceful partner for our clients. We help at any stage of a protein project. Our goal is to become your preferred outsourcing choice for Protein Services and we will work hard to earn your business. Maximize Project Success with Our Expert Protein Services! Protein Expression - generation of heterologous recombinant proteins in multiple expression systems. Fermentation & Cell Culture - bacterial, yeast, insect and mammalian biomass production for scale up processes. Protein Purification - homogeneous and well-characterized preparations save time, effort and resources. Protein Characterization - Customized design to address specific protein characterization goals. Functional Assays & Assay Development - Protocols with detection by UV-Vis, fluorescence or luminescence spectroscopy. ELISA Development - from selection of assay components to development of a working protocol. Protein Labeling & Conjugation - development of strategies to maximize functionality of modified proteins. Endotoxin Removal & Testing - expert service in less than 1 week. Antibody Development & Production - from generation of antigen to characterization of antibodies.

Aspira Women’s Health Inc. is transforming women’s gynecological health with the discovery, development, and commercialization of innovative testing options for women of all races and ethnicities, starting with ovarian cancer. Our ovarian cancer risk assessment portfolio is marketed to healthcare providers as OvaSuite℠, which includes OvaWatch℠, a non-invasive, blood-based test intended for use in the initial clinical assessment of ovarian cancer risk in women with benign or indeterminate adnexal masses for which surgical intervention may be either premature or unnecessary. With a negative predictive value (NPV) of 99%, OvaWatch allows physicians to confidently rule out ovarian cancer malignancy and choose the appropriate clinical management for the right patient at the right time. Ova1Plus® combines our FDA-cleared products, Ova1® and Overa®, to detect risk of ovarian malignancy in women with adnexal masses planned for surgery. EndoCheck℠, Aspira’s first-of-its-kind non-invasive diagnostic test for endometriosis, is currently in development. Visit our website for more information at www.aspirawh.com.

BD is one of the largest global medical technology companies in the world and is advancing the world of health™ by improving medical discovery, diagnostics and the delivery of care. The company supports the heroes on the frontlines of health care by developing innovative technology, services and solutions that help advance both clinical therapy for patients and clinical process for health care providers. BD and its more than 70,000 employees have a passion and commitment to help enhance the safety and efficiency of clinicians' care delivery process, enable laboratory scientists to accurately detect disease and advance researchers' capabilities to develop the next generation of diagnostics and therapeutics. BD has a presence in virtually every country and partners with organizations around the world to address some of the most challenging global health issues. By working in close collaboration with customers, BD can help enhance outcomes, lower costs, increase efficiencies, improve safety and expand access to health care. For more information on BD, please visit bd.com. See community guidelines here: https://tinyurl.com/yunjmzkx.

CheminPharma is a biotechnology services company based in Woodbridge, CT. Founded in 2007, the main objective is to provide high-quality medicinal chemistry focused drug discovery services to biotechnology and pharmaceutical sector. In recent years, CheminPharma has expanded into other closely related businesses. CheminPharma's business rests on the following two pillar strategies: 1. Drug discovery research services 2. Novel Research tools & reagents We are looking to form partnerships with small molecule biotechnology and pharmaceutical companies where we can provide essential chemistry services to aid in the drug discovery process. If you are interested in a collaboration opportunity, feel free to contact us directly!

LEADING THE SUPPLY OF HIGH QUALITY GENERIC APIs 21st Century economic, social, technical and regulatory dynamics are dramatically changing the pharmaceutical world making it more challenging than ever to find profitable opportunities. That's why it's important to work with a supply-partner who knows how to navigate through the tough issues, help you overcome obstacles and get you to the market fast to gain competitive advantage. Established in 1982, ChemWerth is a full service generic drug development and supply company providing high quality API's to regulated markets worldwide. Through exclusive development and partnerships with API manufacturers, ChemWerth provides expertise in product selection, development, analytical and regulatory services, and strong project management to ensure the highest standards of quality. We are committed to providing our customers with a distinct competitive advantage. Our team of technical, analytical, regulatory and marketing experts can enhance your business by: 1. Advancing your product development; 2. Ensuring the manufacturing facilities we represent maintain a high level of compliance with ever-evolving cGMPs; 3. Collaborating with manufacturers in establishing appropriate protocols and methodologies to prepare a sound and complete DMF; 4. Sourcing APIs from China, India, Germany and the US to provide our customers with the best value; and 5. Advancing Paragraph IV filings through our exclusive API development and supply partnerships.

CooperSurgical is driven to advance the care of women, babies, and families around the world. We believe in empowering individuals and healthcare professionals in making health and life choices. We are trusted by clinicians worldwide for products, technologies, and services that support a wide range of reproductive solutions, from contraception to fertility and preventative and therapeutic gynecological care.

Detect builds tools that empower people to understand their health and make informed, timely decisions. Led by Founder Dr. Jonathan Rothberg, the Detect team is redesigning the future of healthcare with the power of technology. Detect wants to make fast, accurate diagnostic testing as routine as taking your temperature and as accessible as telemedicine.

DIANT® offers break-through nanoparticle processing tools and services for a large variety of particle modalities. DIANT® Pharma’s system for continuous production overcomes the challenges of traditional batch processes by providing better control, scalability, real-time monitoring and feedback, regulatory acceptance, reduction in unit operations, and highquality outputs. Our proprietary continuous manufacturing system for nanoparticles has a widest array of applications within the biopharmaceutical and Cell/Gene Therapy industry.

Enrich Biosystems develops a highly integrated microfluidics-free high-throughput cell imaging/analysis/capture platform to accelerate cell-based biology and therapy discovery, precision medicine, and many other critical life science applications. Its bench-top instrument enables short and long-term studies of interactions between living cells. The need for these studies is extensive, including cancer, immunology, and stem cells, in activities ranging from pure research to human clinical therapies. Enrich technology was invented by scientists who were struggling with the complex workflow of monitoring cell/cell interactions using microfluidics-based tools. It is straightforward to use, providing a low-risk, affordable tool for any academic and industrial labs.

The Swoop® system brings MR brain imaging within reach. Our mission is to revolutionize patient care globally through transformational, accessible, clinically relevant diagnostic imaging and data solutions. Hyperfine, Inc. (Nasdaq: HYPR) is the groundbreaking medical technology company that has redefined brain imaging with the Swoop® system—the world's first FDA-cleared, portable, ultra-low-field, magnetic resonance brain imaging system capable of providing imaging at multiple points of care. The Swoop® system received initial U.S. Food and Drug Administration (FDA) clearance in 2020. It is a portable ultra-low field magnetic resonance imaging device for producing images that display the internal structure of the head where full diagnostic examination is not clinically practical. When interpreted by a trained physician, these images provide information that can be useful in determining a diagnosis.

MCRA is the leading global full-service medical device, diagnostics, and biologics CRO and consulting advisory firm. MCRA delivers to its client's industry experience, integrating its seven business value creators: regulatory, clinical research, reimbursement, healthcare compliance, quality assurance, due diligence and distribution logistics to provide a dynamic, market-leading effort from innovation conception to commercialization. MCRA's integrated application of these key value-creating initiatives provides unparalleled value for its clients. MCRA has offices in Washington, DC, Hartford, CT, New York, NY, London, England, Winterthur, Switzerland, Eschborn, Germany and Tokyo, Japan and serves nearly 1,000 clients globally. Its core focus areas of therapeutic experience include orthopedics, spine, biologics, cardiovascular, diagnostic imaging, wound care, artificial intelligence, dental, anesthesia, general surgery, digital health, neurology, robotics, oncology, general and plastic surgery, urology, and in vitro diagnostic (IVD) devices and medical device cybersecurity. MCRA places particular emphasis on its expertise working with companies in all stages of development and throughout the technology life cycle by ushering technologies from the conceptual pre-clinical stage to market approval.

With over 20 years of expertise, NorthEast BioAnalytical Laboratories LLC, also known as NorthEast BioLab, specializes in providing top-notch GLP and clinical bioanalytical services. We are proud to be trusted partners to hundreds of industry sponsors and renowned investigators in the biotechnology sector. We are an independent, full-service facility that adheres to GLP/GCLP compliance. Our FDA-audited and DEA & CT State Schedule II-IV approved facility is managed by Watson LIMS, ensuring seamless operations. Our dedicated scientists and project teams excel in assay development, optimization, troubleshooting, and full method validation on various platforms, including Ligand Binding Assays (ELISA, Meso Scale Discovery, Luminex, Western Blotting, etc.), Mass Spectrometry Liquid Chromatography (LC-MS/MS, HPLC-UV/DAD/Fluorescence, etc.), and Cell And Gene Therapy platforms (Cell-Based Assay, qPCR and dPCR). With our custom assay development services, we offer comprehensive solutions for pharmacokinetics analysis studies, toxicokinetic safety testing, immunogenicity assay, multiplex cytokine analysis, PD biomarker assessment, biochemical assay, mechanism of action, gene expression, copy number variation investigations, etc. Since its establishment in 2003, our team of dedicated biologists and chemists has been committed to empowering mission-driven biotech. With our vast experience and technical expertise, we deliver exceptional preclinical study and clinical assay development services as a Contract Research Organization (CRO). At NorthEast BioLab, we prioritize top quality and industry-leading turnaround time while offering highly competitive pricing. Our team is dedicated to helping you meet the stringent timelines of various milestones throughout your drug development life-cycle. SPEAK TO OUR SCIENTISTS today to expedite your bioanalytical assay development, validation, and sample analysis!

Founded in 1944, NSF is committed to protecting and improving human health and the environment on a global scale. NSF is an independent organization that facilitates standards development, product certification, testing, auditing, education and risk management for public health and the environment. Manufacturers, regulators and consumers alike look to NSF for the development of public health standards and certification that help protect the world's food, water, health and consumer products. Widely recognized for its scientific and technical expertise in the health and environmental sciences, NSF is a Pan American Health Organization/World Health Organization Collaborating Center on Food Safety, Water Quality and Indoor Environment. NSF operates more than 320,000 square feet of state-of-the-art laboratory space and serves 40,000 clients in more than 180 countries worldwide. Its 3,000 team members include microbiologists, toxicologists, chemists, engineers, and environmental and public health professionals. Visit us at www.nsf.org.

Perosphere Technologies is focused on bringing forth new, Point-of-Care (PoC) solutions that make diagnosis, treatment, and prevention a matter of actionable data. We bring the clarity and confidence needed to transform an incomplete clinical picture and drive the way decisions are made in coagulation.

Phesi has the industry’s most comprehensive and dynamic clinical trials database and predictive analytics tools to help trial sponsors make quick and informed decisions to expedite drug development. Our distinguished team works side-by-side with its clients to analyze data, answer questions, and offer informed solutions to benefit study sponsors, investigators, and ultimately patients. Phesi has been applying its innovative technology and deep expertise to help life sciences companies for over 10 years. Our experts work with study sponsors to drive solutions from clinical development planning through trial implementation to optimize protocol designs, select the best investigator sites, shorten enrollment cycle times, select and manage CROs, and much more.

Plumcare is a healthcare company that provides real-world data for drug discovery and development, as well as DNA insights to empower families in managing their health.

Since its inception in 2011, Precipio’s (NASDAQ: PRPO) vision is to battle the problem of cancer misdiagnosis, by developing innovative technologies that improve diagnostic accuracy and laboratory workflow, delivering better results to patients and their physicians. In addition to robust R&D and commercial departments developing and bringing to market its proprietary products, Precipio also operates a clinical laboratory that serves as a testing ground for company products from its development phase to full utilization within the clinical setting. Precipio’s Products Division develops, produces, and sells proprietary diagnostic products to laboratories. Precipio also has a Clinical Diagnostics Division which operates the company’s CLIA/CAP laboratory, servicing oncologist practices and hospitals to provide comprehensive diagnostic services, while utilizing the same technologies developed by the Products Division.

Quantum-Si is a biotechnology company that focuses on genomics and medical devices.

The SingleTimeMicroneedle Patch allows vaccines to be delivered via transdermal patch that painlessly embeds bodily degradable microneedles in the skin. The microneedles can be programmed for delivery over time and at specific times, requires no refrigeration, and can be self-administered by patients. The core technology of STM is a vaccine patch which can be painlessly applied at a single time on the skin to embed arrays of microneedles (MNs) inside the superficial skin layer (like an invisible tattoo). The MNs are made of a safe biodegradable polymer (used for surgical suture) and pre-programmed to release vaccines repeatedly over a long period, mimicking the effect of multiple prime/booster doses in the traditional vaccination process. The vaccines (including subunit protein-based antigen, vector-based vaccine or mRNAs) are stabilized against high temperatures, thus avoiding the need of cold-chain storage facilities and affirming the antigenicity for a long-term skin embedment. The technology will revolutionize the vaccination process by (1) enabling a high immunogenic efficacy via transdermal delivery, (2) enhancing patient compliance via the use of painless and self-administered skin patch, and (3) removing the logistic/economic burden to store vaccines at high temperatures. This skin patch could also be applied for animal vaccination, offering a high impact on both healthcare and other industry sectors.

TriRx Pharmaceutical Services is a leading global contract development and manufacturing organization (CDMO) that provides comprehensive solutions for the animal health and human pharmaceutical industries. TriRx provides integrated development, manufacturing, and supply services from our network of state-of-the-art facilities across the United States and Europe. Founded by industry veterans, TriRx understands what it means to outsource development and manufacturing of your drug product, and that we are committed to delivering CDMO services at a higher standard of performance. Built on honesty, openness, and integrity, TriRx gives our clients total access to our people and processes, treating your product like its own. TriRx is your partner for advancing products to market. We provide comprehensive development, manufacturing, and packaging capabilities from the clinical- to commercial-scale for both sterile and non-sterile pharmaceutical drug products. Our expertise spans a wide range of services and modalities including: - Biologics - Biotech API - Solid Dose - Drug Development - Analytical Testing - Solutions, Suspensions, and Colloidal Dispersions - Liquids, Creams, Ointments - Fill/Finish - Packaging - Aseptic Compounding - Animal Health Products TriRx maintains strict adherence to the regulatory standards required by the FDA, EMA, and other global health authorities. This, coupled with our rigorous quality control processes, ensures that every product we manufacture meets the highest quality standards. We are more than just a CDMO; we are a trusted partner in the pharmaceutical industry. Whether you are a startup biotech or a multinational pharmaceutical company, TriRx is dedicated to helping you achieve your objectives and bring vital medications to the markets and patients who need them most. Your Product. Your Facility. Your Team. A CDMO You Can Trust.

Ultimate Nutrition was founded in 1979 by Victor H. Rubino. At the time Victor was one of the top amateur power lifters in the United States. Driven by a goal to become the best, Victor knew that supplements were the key to improving his performance through increased strength and faster recovery. Not satisfied with the current supplements that were available to him the 1970's and being a biochemist himself, Victor decided to launch his own company. Thus, Ultimate Nutrition was born. Victor's goal was to create high quality, thoroughly researched products, while remaining at an affordable price for everyone. In the late 1970's and early 1980's Ultimate Nutrition was among the first companies to have Amino Acid tablets, protein powders, carbohydrate powders, and various types of Fat Burners. By the late 1980's and early 1990's Ultimate Nutrition launched several legendary products. By the mid 1990's Ultimate Nutrition again was on the cutting edge as one of the first companies to come out with Whey Protein powder in a bottle. Today, Ultimate Nutrition continues to excel with a wide range of products to meet consumer demand. Some of our most well known and loved products include ProStar® Whey, Iso Sensation® 93, Iso Mass Xtreme Gainer®, Muscle Juice® 2544, GlutaPure®, Ultra Ripped®, and Horse Power® X. Our cutting-edge R&D team has created new products like Pre Gold, Cheat Code, Gold Burn, NutriMEAL, JackT, Chicken Protein Isolate, Protein Fat Burner, Rice-Olate (rice protein), Clean Whey, Natural Gainz, and we launched our Vitality Series of healthy-aging products! Sadly, Victor Rubino passed away in March 2003 at 48 years young. However, Ultimate Nutrition is still owned and operated by the Rubino family to this day. Having built an international following, Ultimate Nutrition is proud to bring our beloved supplements to the U.S. market. Our commitment to Victor's vision remains the same, to create high quality, highly researched products at affordable prices.

Virscio is a specialty translational research organization developing and providing innovative in vivo disease modeling and related preclinical research and development services to meet the preclinical, translational, and regulatory research needs of the pharmaceutical and life sciences industry. We specialize in the fields of ophthalmology, central nervous system, cardiovascular and metabolic related disease and disorders, and have advanced discovery and development programs for a wide range of sponsors, collaborators, and partners around the world, ranging from large pharmaceutical companies and venture-backed biotechnology companies to academic teams seeking to apply the most cutting edge research and development strategies in the most efficient and robust manner.

Wren Laboratories is revolutionizing cancer diagnostics with advanced machine learning and liquid biopsy mRNA-based technology. Our goal is to provide precise, non-invasive diagnostics tailored to each patient's unique molecular profile, transforming early detection and surveillance of cancer for better patient outcomes. With over 100 patents and validation from more than 60 clinical studies, Wren has developed highly sensitive liquid biopsy mRNA gene expression-based assays. These innovative assays aid in cancer diagnosis, detect minimal residual disease (MRD), and predict tumor prognosis and therapeutic response. Our tests, including the NETest for neuroendocrine tumors and PROSTest for prostate cancer, leverage mRNA technology and AI/ML genomic assays for unparalleled molecular insights. This allows accurate detection of cancer markers, empowering personalized care. Our mRNA-based diagnostics are crucial in monitoring patients post-surgery or treatment. Wren also offers Biopharma services with AI/ML liquid biopsy genomic assays for research and companion diagnostics (CDx) development. Our RNA stabilizer tubes preserve whole blood at ambient temperature for up to 10 days, reducing clinical trial logistics. From our CLIA-certified, CAP-accredited, and NYS-licensed lab, our tests ensure high accuracy and reliability. For more information, visit our website and follow us for updates in non-invasive cancer diagnostics.

For more than 300 years, Yale University has inspired the minds that inspire the world. Based in New Haven, Connecticut, Yale brings people and ideas together for positive impact around the globe. A research university that focuses on students and encourages learning as an essential way of life, Yale is a place for connection, creativity, and innovation among cultures and across disciplines.